George Soros's position in SpringWorks Therapeutics is currently worth $27.8 Million. That's 0.87% of their equity portfolio (29th largest holding). The stake costed the investor $25 Million, netting the investor a gain of 11% so far.
Avg closing price
Price range
Increased shares by 7.4% (+41.1 Thousand shares)
Q4 2024
Avg closing price
$35.09
Price range
$28.61
-
$42.55
Increased shares by 45.3% (+174 Thousand shares)
Q3 2024
Avg closing price
$37.43
Price range
$32.04
-
$42.76
Increased shares by 88.8% (+181 Thousand shares)
Q2 2024